Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models
Impact in
- Cancer Research 232
Classified as
- Authors
- M. SchulteAllie FuPing ZhaoJun LiLing Geng
- Journal
- Nature Medicine
In The Last Decade
doi.org/10.1038/nm.4464 →Countries where authors are citing Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models
This map shows the geographic impact of Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models more than expected).
Fields of papers citing Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models
This network shows the impact of Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models.
About Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models
This paper, published in 2018, received 391 indexed citations . Written by M. Schulte, Allie Fu, Ping Zhao, Jun Li, Ling Geng, Shannon T. Smith, Jumpei Kondo, Robert J. Coffey, Marc O. Johnson and Jeffrey C. Rathmell covering the research area of Biochemistry, Cancer Research and Molecular Biology. It is primarily cited by scholars working on Cancer Research (232 citations), Molecular Biology (217 citations), Biochemistry (106 citations), Oncology (55 citations) and Biotechnology (43 citations). Published in Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1038/nm.4464.